Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

To gain a competitive edge in the Enzymes Market, major companies are concentrating on a variety of growth strategies, including partnerships and agreements. For instance, a multi-year, exclusive supply agreement for the supply of a proprietary enzyme was signed by Codexis, Inc., a U.S.-based protein engineering company, and KYORIN Pharmaceuticals Co., Ltd. in February 2019. Vibegron, the active ingredient in Beova Tablets used to treat overactive bladder, will be produced using this enzyme.

Read More:





Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe